MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease

Digestive and Liver Disease

Volumn 41, Issue 4, 2009, Pages 289-297

  Jin, X ^a   Ye, Y F ^a   Chen, S H ^a   Yu, C H ^a   Liu, J ^a   Li, Y M ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Microarray; MicroRNA; Nonalcoholic fatty liver disease; Stem loop RT PCR

Indexed keywords

GLUCOSE; LIPID; MICRORNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FATTY LIVER; GENE EXPRESSION PROFILING; GENE TARGETING; GLUCOSE METABOLISM; LIPID METABOLISM; LIVER PARENCHYMA; MICROARRAY ANALYSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION REGULATION; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX;

EID: 62049083189     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.08.008     Document Type: Article

References (48)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
2. Patrick L. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 7 (2002) 276-291
3. Day C.P., and James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
4. Lau N.C., Lim L.P., Weinstein E.G., and Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294 (2001) 858-862
5. Ambros V. The functions of animal microRNAs. Nature 431 (2004) 350-355
6. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
7. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408 (2000) 86-89
8. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
9. Brennecke J., Hipfner D.R., Stark A., Russell R.B., and Cohen S.M. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113 (2003) 25-36
10. Chen C.Z., Li L., Lodish H.F., and Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004) 83-86
11. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 6 (2006) 857-866
12. Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. J Am Med Assoc 297 (2007) 1901-1908
13. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120 (2007) 1046-1054
14. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25 (2006) 2537-2545
15. Lanza G., Ferracin M., Gafa R., Veronese A., Spizzo R., Pichiorri F., et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 6 (2007) 54
16. Jay C., Nemunaitis J., Chen P., Fulgham P., and Tong A.W. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol 26 (2007) 293-300
17. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., and Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2007) 647-658
18. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27 (2008) 2128-2136
19. Naraba H., and Iwai N. Assessment of the microRNA system in salt-sensitive hypertension. Hypertens Res 28 (2005) 819-826
20. Ikeda S., Kong S.W., Lu J., Bisping E., Zhang H., Allen P.D., et al. Altered microRNA expression in human heart disease. Physiol Genomics 31 (2007) 367-373
21. Esau C., Kang X., Peralta E., Hanson E., Marcusson E.G., Ravichandran L.V., et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279 (2004) 52361-52365
22. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3 (2006) 87-98
23. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 (2004) 226-230
24. Jin X., Yu C.H., Lv G.C., and Li Y.M. Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats. World J Gastroenterol 13 (2007) 1732-1736
25. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
26. Vester B., and Wengel J. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry 43 (2004) 13233-13241
27. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33 (2005) e179
28. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res 32 Database issue (2004) D109-D111
29. Olson N.E. The microarray data analysis process: from raw data to biological significance. NeuroRx 3 (2006) 373-383
30. Tibshirani R., Hastie T., Narasimhan B., and Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99 (2002) 6567-6572
31. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95 (1998) 14863-14868
32. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., and Burge C.B. Prediction of mammalian microRNA targets. Cell 115 (2003) 787-798
33. John B., Enright A.J., Aravin A., Tuschl T., Sander C., and Marks D.S. Human MicroRNA targets. PLoS Biol 2 (2004) e363
34. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nat Genet 37 (2005) 495-500
35. Ai Z.L., and Chen D.F. The significance and effects of liver X receptor alpha in nonalcoholic fatty liver disease in rats. Zhonghua Gan Zang Bing Za Zhi 15 (2007) 127-130
36. Liu C.G., Calin G.A., Meloon B., Gamliel N., Sevignani C., Ferracin M., et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 101 (2004) 9740-9744
37. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
38. Diehl A.M., Li Z.P., Lin H.Z., and Yang S.Q. Cytokines and the pathogenesis of non-alcoholic steatohepatitis. Gut 54 (2005) 303-306
39. Chitturi S., Abeygunasekera S., Farrell G.C., Holmes-Walker J., Hui J.M., Fung C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
40. He A., Zhu L., Gupta N., Chang Y., and Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 21 (2007) 2785-2794
41. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102 (2005) 13944-13949
42. Taganov K.D., Boldin M.P., Chang K.J., and Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103 (2006) 12481-12486
43. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141 (2008) 672-675
44. Novina C.D., and Chabner B.A. RNA-directed therapy: the next step in the miRNA revolution. Oncologist 13 (2008) 1-3
45. Jeyaseelan K., Herath W.B., and Armugam A. MicroRNAs as therapeutic targets in human diseases. Expert Opin Ther Targets 11 (2007) 1119-1129
46. Esau C.C. Inhibition of microRNA with antisense oligonucleotides. Methods 44 (2008) 55-60
47. Shin K.J., Wall E.A., Zavzavadjian J.R., Santat L.A., Liu J., Hwang J.I., et al. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci U S A 103 (2006) 13759-13764
48. Anstee Q.M., and Goldin R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87 (2006) 1-16